Trials / Recruiting
RecruitingNCT06010641
Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3)
Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3): a Prospective, Randomized, Open-label, Blinded-endpoint, Multi-center Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- General Hospital of Shenyang Military Region · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The effect of head position as a nonpharmacological therapy on acute ischemic stroke (AIS) remains inconclusive. Recent HOPES2 (Head dOwn-Position for acutE moderate ischemic Stroke with large artery atherosclerosis) suggest the safety, feasibility, and potential benefit of the head-down position (HDP) in acute ischemic stroke. The current study aims to investigate the efficacy and safety of HDP in acute moderate ischemic stroke patients with large artery atherosclerosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | head-down position | -20° Trendelenburg as an adjunct to guideline-based treatment, |
Timeline
- Start date
- 2024-01-10
- Primary completion
- 2026-10-30
- Completion
- 2026-10-30
- First posted
- 2023-08-24
- Last updated
- 2025-03-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06010641. Inclusion in this directory is not an endorsement.